Libo Chen

5PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 23, 2026
Sequential Therapy with Anlotinib and Radioiodine for Distant Metastatic Differentiated Thyroid Cancer: A Phase II Clinical Trial.

|Mar 18, 2025
Limited value of genetic profiling in guiding radioiodine therapy for metastatic differentiated thyroid cancer.

Ziyan He, Congcong Wang, Chang Liu

|Feb 23, 2022
Poorly differentiated thyroid carcinoma: a clinician's perspective.

Junyu Tong, Maomei Ruan, Yuchen Jin

|Jan 21, 2022
Initial or salvage treatment with apatinib shows promise against radioiodine-refractory differentiated thyroid carcinoma.

Xian Qiu, Lin Cheng, Ri Sa

|Jan 24, 2020
Combined tazemetostat and MAPKi enhances differentiation of papillary thyroid cancer cells harbouring BRAFV600E by synergistically decreasing global trimethylation of H3K27.

Hao Fu, Lin Cheng, Ri Sa

Pageof 1

Frequent Collaborators

1 joint publications

Zhiyan Liu

1 joint publications

Yifan Zhang